✦ LIBER ✦

Treatment of psoriatic arthritis with oral 1,25-dihydroxyvitamin D3: a pilot study

✍ Scribed by David Huckins; David T. Felson; Michael Holick

Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 416 KB
Volume: 33
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.1780331117

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development of acute erythremia from mye

Development of acute erythremia from myelodysplastic syndrome after treatment with 1,25-dihydroxyvitamin D3

✍ Masahiro Kizaki; Nobuyuki Takayama; Yohko Kawai; Shin-ichiro Okamoto; Yasuo Iked 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 441 KB 👁 2 views

Treatment with 1,25-dihydroxyvitamin D3

Treatment with 1,25-dihydroxyvitamin D3 reduces impairment of human osteoblast functions during cellular aging in culture

✍ Marie Kveiborg; Suresh I.S. Rattan; Brian F.C. Clark; Erik F. Eriksen; Moustapha 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 227 KB

Alefacept in combination with methotrexa

Alefacept in combination with methotrexate for the treatment of psoriatic arthritis: Results of a randomized, double-blind, placebo-controlled study

✍ Philip J. Mease; Dafna D. Gladman; Edward C. Keystone 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB 👁 2 views

## Abstract ## Objective To evaluate the efficacy and safety of alefacept in combination with methotrexate (MTX) for the treatment of psoriatic arthritis (PsA). ## Methods Patients were eligible for this randomized, double‐blind, placebo‐controlled trial if they were ages 18–70 years and had act

Infliximab inhibits progression of radio

Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment: Results from the induction and maintenance psoriatic arthritis clinical trial 2

✍ D. van der Heijde; A. Kavanaugh; D. D. Gladman; C. Antoni; G. G. Krueger; C. Guz 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 2 views

Inhibition of proliferation and inductio

Inhibition of proliferation and induction of differentiation of osteoblastic cells by a novel 1,25-dihydroxyvitamin D3 analog with an extensively modified side chain (CB1093)

✍ Sanna Ryhänen; Tiina Jääskeläinen; Janne T.A. Saarela; Pekka H. Mäenpää 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB 👁 1 views

1,25-Dihydroxyvitamin D3 (1,25D) is involved in the regulation of proliferation and differentiation of a variety of cell types including cancer cells. In recent years, numerous new vitamin D3 analogs have been developed in order to obtain favorable therapeutic properties. The effects of a new 20-epi

An oral Syk kinase inhibitor in the trea

An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: A three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents

✍ Mark C. Genovese; Arthur Kavanaugh; Michael E. Weinblatt; Charles Peterfy; Julie 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB 👁 1 views